Preparation and application of novel haemagglutination antigen used for preventing infection with avian influenza virus
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- NINGBO XINAN MEDICAL SCI & TECH
- Publication Date
- 2015-06-17
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the preparation of a hemagglutinin antigen, in particular to the preparation and application of a novel hemagglutinin antigen for preventing avian influenza virus infection. Background technique
[0002] Bird flu and seasonal flu are problems that plague the world. Infection of the latest H10N8 avian influenza virus to humans is an urgent problem to be solved.
[0003] Pandemic influenza is a more serious illness than seasonal flu. For example, the 1918 "Spanish" flu caused 40 to 100 million deaths worldwide. The 2009-2010 H1N1 swine flu spread rapidly around the world and was defined by the WHO as the first major flu in the 21st century. Highly pathogenic avian influenza (HPAI) viruses may cause future pandemics. For example, the increasing number of cases of H5N1 avian influenza virus infection has also shown the possibility of causing a pandemic. Other potential pandemics include the H7N2 and H9N2 avian influenza viruse...